SCHEMBL13166108

SCHEMBL13166108

N#Cc1c(NC(=O)/C=C/c2cccnc2)sc2c1CCN(C(=O)Oc1ccccc1)C2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.49
KMT2A Q03164 7/20 0.49
GAA P10253 3/20 0.49
POLB P06746 3/20 0.49
STAT3 P40763 5/20 0.47
GRM1 Q13255 3/20 0.46
MAPT P10636 6/20 0.46
ALDH1A1 P00352 5/20 0.46
TGFBR1 P36897 1/20 0.45
KDM4E B2RXH2 2/20 0.44
LMNA P02545 3/20 0.43
HPGD P15428 2/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NR0B1 P51843 1/20 0.42
ALOX15 P16050 1/20 0.42
HSD17B10 Q99714 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
MITF O75030 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3351584 1.00 MEN1 (0.49) MEN1KMT2AGAAPOLBSTAT3
SCHEMBL3355093 0.93 MEN1 (0.53) MEN1KMT2AGAAPOLBSTAT3
SCHEMBL13166265 0.93 MEN1 (0.53) MEN1KMT2AGAAPOLBSTAT3
SCHEMBL3351009 0.91 MAPT (0.49) MEN1KMT2AGAAPOLBSTAT3
SCHEMBL13166277 0.91 MAPT (0.49) MEN1KMT2AGAAPOLBSTAT3
SCHEMBL3354384 0.91 MEN1 (0.55) MEN1KMT2AGAAPOLBSTAT3
SCHEMBL13166106 0.91 MEN1 (0.55) MEN1KMT2AGAAPOLBSTAT3
SCHEMBL3354670 0.90 STAT3 (0.51) MEN1KMT2AGAAPOLBSTAT3
SCHEMBL13166105 0.90 STAT3 (0.51) MEN1KMT2AGAAPOLBSTAT3
SCHEMBL13166279 0.90 STAT3 (0.48) MEN1KMT2AGAAPOLBSTAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7803945-B2 Tetrahydropyridothiophenes 4SC AG (DE) 2010-09-28 US disclosed
US-7723523-B2 Tetrahydropyridothiophenes 4SC AG (DE) 2010-05-25 US disclosed
US-7723523-B2 Tetrahydropyridothiophenes 4SC AG (DE) 2010-05-25 US disclosed
US-20090270378-A1 NOVEL TETRAHYDROPYRIDOTHIOPHENES NYCOMED GMBH (DE) 2009-10-29 US disclosed
US-20070244112-A1 Novel tetrahydropyridothiophenes ALTANA PHARMA AG (DE) 2007-10-18 US disclosed
US-20070244112-A1 Novel tetrahydropyridothiophenes ALTANA PHARMA AG (DE) 2007-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270378-A1 NOVEL TETRAHYDROPYRIDOTHIOPHENES BAX, BCL2, CCAR2 MEN1 4646/4885KMT2A 2220/4885GAA 4376/4885
US-20070244112-A1 Novel tetrahydropyridothiophenes BAX, BCL2, BAD MEN1 4610/4885KMT2A 2358/4885GAA 4265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.